ALZAMEND NEURO, INC. Shares Outstanding (Cover Page)
ALZAMEND NEURO, INC. (ALZN) had Shares Outstanding (Cover Page) of 4.83 million shares as of 2026-09-10, per its 10-Q filed 2026-09-10.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-09-10
- 2026-09-10: Entity Common Stock, Shares Outstanding 4.83M shares.
- 2026-07-22: Entity Common Stock, Shares Outstanding 4.79M shares.
- 2026-03-11: Entity Common Stock, Shares Outstanding 3.80M shares.
- 2025-12-09: Entity Common Stock, Shares Outstanding 3.80M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-09-10 | 4.83M shares 10-Q · filed 2026-09-10 |
| 2026-07-22 | 4.79M shares 10-K · filed 2026-07-22 |
| 2026-03-11 | 3.80M shares 10-Q · filed 2026-03-11 |
| 2025-12-09 | 3.80M shares 10-Q · filed 2025-12-09 |
| 2025-09-10 | 3.14M shares 10-Q · filed 2025-09-10 |
| 2025-07-22 | 2.90M shares 10-K · filed 2025-07-22 |
| 2025-03-07 | 6.60M shares 10-Q · filed 2025-03-10 |
| 2024-12-10 | 5.43M shares 10-Q · filed 2024-12-11 |
| 2024-09-11 | 3.89M shares 10-Q · filed 2024-09-11 |
| 2024-07-29 | 841.24K shares 10-K · filed 2024-07-30 |
| 2024-03-22 | 6.87M shares 10-Q · filed 2024-03-25 |
| 2023-12-14 | 7.12M shares 10-Q · filed 2023-12-15 |
| 2023-09-12 | 96.94M shares 10-Q · filed 2023-09-13 |
| 2023-07-24 | 96.94M shares 10-K · filed 2023-07-27 |
| 2023-03-15 | 96.44M shares 10-Q · filed 2023-03-15 |
| 2022-12-12 | 96.43M shares 10-Q · filed 2022-12-12 |
| 2022-09-13 | 95.48M shares 10-Q · filed 2022-09-13 |
| 2022-07-19 | 95.48M shares 10-K · filed 2022-07-19 |
| 2022-03-15 | 90.10M shares 10-Q · filed 2022-03-15 |
| 2021-12-13 | 88.85M shares 10-Q · filed 2021-12-13 |
| 2021-09-13 | 86.89M shares 10-Q · filed 2021-09-13 |
| 2021-07-20 | 85.30M shares 10-K · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |